Company Filing History:
12 out of 15,471 
6 out of 37 
1 out of 832,812 Years Active: 1992-2006
Title: Innovator Spotlight: Jon R Polansky - Pioneering Glaucoma Diagnostic and Treatment Methods
Introduction:
In the world of innovation and patents, there are individuals who make significant contributions to scientific advancements and healthcare solutions. One such remarkable inventor is Jon R Polansky, based in Mill Valley, CA. With an impressive portfolio of 19 patents, Polansky has made noteworthy contributions to the field of glaucoma diagnosis, prognosis, and treatment. Let's delve into his latest patents, career highlights, and collaborations in this article.
Latest Patents:
Jon R Polansky’s groundbreaking patents in the field of glaucoma diagnosis and treatment have greatly impacted the medical community. Specifically, his recent patents revolve around nucleic acids, kits, and methods for the diagnosis, prognosis, and treatment of glaucoma and related disorders. Polansky's inventions incorporate the use of upstream sequences of the TIGR protein encoding sequence, enabling the diagnosis of steroid sensitivity and identifying the risk factors for glaucoma and ocular hypertensive disorders. Additionally, the patents encompass nucleic acids, kits, and methods that include polymorphisms, base substitutions, or base additions within the upstream and protein-encoding regions of the TIGR gene. These inventions pave the way for novel diagnostic, prognostic, and therapeutic approaches.
Career Highlights:
Polansky has had an illustrious career, making significant contributions in both academia and the industry. He has collaborated with prestigious institutions, including the University of California. Through his work at the university, Polansky has contributed to advancing the understanding and treatment of glaucoma. Additionally, he has collaborated with InSite Vision Corporation, a prominent company in eye care innovation. His work with these esteemed organizations has solidified his status as a leading innovator in the field.
Collaborations:
Collaboration has been essential to Polansky's success, as evident from his partnerships with notable individuals. Among his colleagues, Thai D Nguyen and Weidong Huang stand out. Together, they have worked on cutting-edge projects and research related to glaucoma diagnosis and treatment methods. Polansky's collaborations reflect his commitment to interdisciplinary approaches and the collective pursuit of groundbreaking solutions.
Conclusion:
Jon R Polansky's contributions to the field of glaucoma diagnostic and treatment methods have significantly impacted the medical world. With an impressive portfolio of 19 patents, his innovative solutions using nucleic acids and upstream sequences of the TIGR gene have opened new avenues for diagnosing, prognosing, and treating glaucoma and related disorders. Collaborating with esteemed institutions and colleagues, Polansky continues to push the boundaries of glaucoma research and treatment. His work serves as an inspiration for aspiring inventors and underscores the importance of innovation in healthcare.